Literature DB >> 12835383

Endothelial and steroidogenic cell migration are regulated by WNT4 in the developing mammalian gonad.

Katherine Jeays-Ward1, Christine Hoyle, Jennifer Brennan, Mathieu Dandonneau, Graham Alldus, Blanche Capel, Amanda Swain.   

Abstract

The signalling molecule WNT4 has been associated with sex reversal phenotypes in mammals. Here we show that the role of WNT4 in gonad development is to pattern the sex-specific vasculature and to regulate steroidogenic cell recruitment. Vascular formation and steroid production in the mammalian gonad occur in a sex-specific manner. During testis development, endothelial cells migrate from the mesonephros into the gonad to form a coelomic blood vessel. Leydig cells differentiate and produce steroid hormones a day later. Neither of these events occurs in the XX gonad. We show that WNT4 represses mesonephric endothelial and steroidogenic cell migration in the XX gonad, preventing the formation of a male-specific coelomic blood vessel and the production of steroids. In the XY gonad, Wnt4 expression is downregulated after sex determination. Transgenic misexpression of Wnt4 in the embryonic testis did not inhibit coelomic vessel formation but vascular pattern was affected. Leydig cell differentiation was not affected in these transgenic animals and our data implies that Wnt4 does not regulate steroidogenic cell differentiation but represses the migration of steroidogenic adrenal precursors into the gonad. These studies provide a model for understanding how the same signalling molecule can act on two different cell types to coordinate sex development.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12835383     DOI: 10.1242/dev.00591

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  97 in total

1.  Overactivation of hedgehog signaling alters development of the ovarian vasculature in mice.

Authors:  Yi Ren; Robert G Cowan; Fernando F Migone; Susan M Quirk
Journal:  Biol Reprod       Date:  2012-06-07       Impact factor: 4.285

2.  Sox3 is required for gonadal function, but not sex determination, in males and females.

Authors:  Jeffrey Weiss; Joshua J Meeks; Lisa Hurley; Gerald Raverot; Andrea Frassetto; J Larry Jameson
Journal:  Mol Cell Biol       Date:  2003-11       Impact factor: 4.272

3.  Microarray analysis reveals novel gene expression changes associated with erectile dysfunction in diabetic rats.

Authors:  Chris J Sullivan; Thomas H Teal; Ian P Luttrell; Khoa B Tran; Mette A Peters; Hunter Wessells
Journal:  Physiol Genomics       Date:  2005-08-23       Impact factor: 3.107

Review 4.  The pathway to femaleness: current knowledge on embryonic development of the ovary.

Authors:  Humphrey Hung-Chang Yao
Journal:  Mol Cell Endocrinol       Date:  2005-01-31       Impact factor: 4.102

Review 5.  Temperature, genes, and sex: a comparative view of sex determination in Trachemys scripta and Mus musculus.

Authors:  Humphrey H-C Yao; Blanche Capel
Journal:  J Biochem       Date:  2005-07       Impact factor: 3.387

Review 6.  The road to maleness: from testis to Wolffian duct.

Authors:  Ivraym Barsoum; Humphrey Hung-Chang Yao
Journal:  Trends Endocrinol Metab       Date:  2006-07-05       Impact factor: 12.015

Review 7.  Adrenocortical stem and progenitor cells: unifying model of two proposed origins.

Authors:  Michelle A Wood; Gary D Hammer
Journal:  Mol Cell Endocrinol       Date:  2010-11-20       Impact factor: 4.102

Review 8.  SRY and the standoff in sex determination.

Authors:  Leo DiNapoli; Blanche Capel
Journal:  Mol Endocrinol       Date:  2007-07-31

Review 9.  Wnt signaling in ovarian tumorigenesis.

Authors:  T A Gatcliffe; B J Monk; K Planutis; R F Holcombe
Journal:  Int J Gynecol Cancer       Date:  2007-11-06       Impact factor: 3.437

10.  Wnt/β-catenin pathway is regulated by PITX2 homeodomain protein and thus contributes to the proliferation of human ovarian adenocarcinoma cell, SKOV-3.

Authors:  Moitri Basu; Sib Sankar Roy
Journal:  J Biol Chem       Date:  2012-12-17       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.